{"transactions":[{"id":958326,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO and Director"}}],"security":"Common Stock","published_at":"2025-12-29T16:01:19.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":52204,"price":2.03,"value":105974.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired 52,204 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025."}],"balance_after":101074,"source":{"system":"sec-edgar","filing":"0001493152-25-029354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315225029354/ownership.xml","form_type":"4"}},{"id":1388178,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T16:05:15.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.105,"expiration_date":"2034-10-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-040730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315224040730/ownership.xml","form_type":"4"}},{"id":1673211,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T16:15:43.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":43250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027."}],"balance_after":43250,"derivative":{"exercise_price":1.74,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":43250},"source":{"system":"sec-edgar","filing":"0001493152-24-003447","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315224003447/ownership.xml","form_type":"4"}},{"id":2049873,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T16:05:43.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":43250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026."}],"balance_after":43250,"derivative":{"exercise_price":1.61,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":43250},"source":{"system":"sec-edgar","filing":"0001493152-23-002019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315223002019/ownership.xml","form_type":"4"}},{"id":2417064,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Common Stock","published_at":"2022-02-02T17:08:10.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":14130,"price":5.003,"value":70692.39,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009."}],"balance_after":1368356,"source":{"system":"sec-edgar","filing":"0001493152-22-003002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315222003002/ownership.xml","form_type":"4"}},{"id":2417063,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Common Stock","published_at":"2022-02-02T17:08:10.000Z","date":"2022-01-31","kind":"sale","acquired":false,"shares":5870,"price":5.0001,"value":29350.587,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of (i) 1,355,654 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009."}],"balance_after":1382486,"source":{"system":"sec-edgar","filing":"0001493152-22-003002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315222003002/ownership.xml","form_type":"4"}},{"id":2422775,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T16:31:25.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":43350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":43350,"derivative":{"exercise_price":4.9,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":43350},"source":{"system":"sec-edgar","filing":"0001493152-22-002556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315222002556/ownership.xml","form_type":"4"}},{"id":2611800,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70836,"kind":"person","name":"Newman Michael James","position":1,"cik":"0001876315","reported_name":"Newman Michael James","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CSO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-06T17:00:35.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":290000,"derivative":{"exercise_price":8.87,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001493152-21-018904","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876315/000149315221018904/ownership.xml","form_type":"4"}}]}